1 World Health Organization. World Health Statistics 2014. World Health Organization 2014:175.
2 J. He, D. Gu, X. Wu, et al.Major causes of death among men and women in China. N Engl J Med, 353 (2005), pp. 1124-1134.
3 J. He, D. Gu, J. Chen, et al.Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet, 374 (2009), pp. 1765-1772.
4 O\\\'Meara JG, Kardia SR, Armon JJ, Brown C, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004; 164:1313-8.
5 Laaksonen DE, Niskanen L, Nyyssönen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29(20):2561–8. https://doi.org/10.1093/eurheartj/ehn061.
6 Sesso HD, Buring JE, Chown MJ, Ridker PM, Gaziano JM. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005; 165(20):2420–7. https://doi.org/10.1001/archinte.165.20.2420.
7 Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension, 47(1), 45–50. doi:10.1161/01.hyp.0000196306.42418.0e
8 Memon AR, Shaikh F, Memon ZA, Majeed Adnan BA. Assessment of lipid profile and serum total protien in patients of hypertension. Ann Pak Inst Med Sci. 2017;13(2):246–8.
9 Nordestgaard, B. G., and A. Varbo. 2014. Triglycerides and cardiovascular disease. The Lancet 384 (9943):626-635.
10 Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012; 380: 601.
11 Janghorbani, M., Bonnet, F., & Amini, M. (2015). Glucose and the risk of hypertension in first- degree relatives of patients with type 2 diabetes. Hypertension Research, 38(5), 349 doi:10.1038/hr.2015.10.
12 Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al., EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373:2117–2128.
13 Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al., LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016; 375:311–322.
14 Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment-a position paper of the obesity society and the American society of hypertension. Obesity 2013;21:8–24.
15 Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. Clin Chim Acta 2017;464:57–63.
16 De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. The American journal of physiology. 1979;237(3): E214–23. PMID: 382871.
17 Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World J Diabetes. 2010;1(2):36-47.
18 Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol 2014;13: 146.
19 Navarro-Gonzalez D, Sanchez-Inigo L, Pastrana-Delgado J, Fernandez-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular Metabolic CUN cohort. Prev Med 2016;86: 99-105.
20 Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008;6: 299-304.
21 Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi: 10.1016/j.diabres.2011.05.030.
22 Jian S, Su‑Mei N, Xue C, Jie Z, Xue‑sen W. Association and interaction between triglyceride– glucose index and obesity on risk of hypertension in middle‑aged and elderly adults. Clin Exp Hypertens. 2017;39:732–9.
23 Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17:41. https ://doi.org/10.1186/s1293 3‑018‑0692‑1.
24 Lambrinoudaki I, Kazani MV, Armeni E, Georgiopoulos G, Tampakis K, Rizos D, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Hear Lung Circ. 2018;27:716–24.
25 Kim MK, Ahn CW, Kang S, Nam JS, Kim KR, Park JS. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16:108. https ://doi.org/10.1186/s1293 3‑017‑0589‑4.
26 Mao, Q., D. Zhou, Y. Li, Y. Wang, S. C. Xu, and X. H. Zhao. 2019. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST- Segment Elevation Acute Coronary Syndrome. Dis Markers 2019:6891537.
27 Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC)study. PLoS One 2014;9: e90430.
28 Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovasc Diabetol 2017;16: 30.
29 Navarro-Gonzalez D, Sanchez-Inigo L, Pastrana-Delgado J, Fernandez-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The VascularMetabolic CUN cohort. Prev Med 2016;86: 99-105.
30 Lee DY, Lee ES, Kim JH, Park SE, Park CY, Oh KW, et al. Predictive Value of Triglyceride Glucose Index for the Risk of Incident Diabetes: A 4-Year Retrospective Longitudinal Study. PLoS One 2016;11: e0163465.
31 Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al. Modifed glomerular fltration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.
32 2016 Chinese guideline for the management of dyslipidemia in adults. ChinJ Health Manage, February 2017, Vol 11, No .1.
33 International Expert Committee. International Expert Committee report on the role of the A1C assay
in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
34 WHO Guidelines Approved by the Guidelines Review Committee. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva, 2011.
35 Predictive Values of Body Mass Index and Waist Circumference for Risk Factors of Certain Related Diseases in Chinese Adults - Study on Optimal Cut-off Points of Body Mass Index and Waist Circumference in Chinese Adults[J].Biomedical and Environmental Sciences,2002(01):83- 96.
36 Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179‐c184. doi:10.1159/000339789
37 Tinsley LJ, Kupelian V, D'Eon SA et al. Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes. J Clin Endocrinol Metab. 2017;102(10):3704-3711.
38 Paneni F, Lüscher TF. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Am J Cardiol. 2017;120(1S): S17-S27.
39 P. Chamroonkiadtikun, et al., The triglyceride-glucose index, a predictor of type 2 diabetes
development: A retrospective cohort study, Prim. Care Diab. (2019), https://doi.org/10.1016/j.pcd.2019.08.004.
40 Borg R, Kuenen JC, Carstensen B et al. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2011;54(1):69- 72.
41 Cavagnolli G, Pimentel AL, Freitas PA et al Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. Clin Chim Acta 2015;445:107-114.
42 McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004;27:1259-1264.
43 Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in middle eastern women. J Hum Hypertens. 2012;26(9):525–532. doi: 10.1038/jhh.2011.70.
44 Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, Kimball TR. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131(4):e1082–e1090. doi: 10.1542/peds.2012-1726.
45 Quijada Z, Paoli M, Zerpa Y, Camacho N, Cichetti R, Villarroel V, Arata-Bellabarba G, Lanes R. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes. 2008;9(5):464–471. doi: 10.1111/j.1399- 5448.2008.00406.x.
46 Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E, Forziato C, Saitta F, Iardino MR, Di Carluccio C, Capaldo B. Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify Cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care. 2012;35(1):158–162. doi: 10.2337/dc11-1456.
47 Moon HK, Kim EG. Comparing validity of body mass index, waist to hip ratio, and waist circumference to cardiovascular disease risk factors in Korean elderly. Korean J Nutr. 2005;38:445–54.
48 Perissinotto E, Pisent C, Sergi G, Grigoletto F; ILSA Working Group (Italian Longitudinal Study on Ageing). Anthropometric measurements in the elderly: age and gender differences. Br J Nutr. 2002;87(2):177‐186. doi:10.1079/bjn2001487.
49 Bogaert, Y. E., & Linas, S. (2009). The role of obesity in the pathogenesis of hypertension. Nature clinical practice. Nephrology, 5(2), 101–111. https://doi.org/10.1038/ncpneph1022.
50 Gharipour M, Sadeghi M, Hosseini M, Andalib E, Boroujeni MB, Sarrafzadegan N. Effect of age on the phenotype of metabolic syndrome in developing country. Adv Biomed Res. 2015;4:103. Published 2015 May 29. doi:10.4103/2277-9175.157796.
51 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for theManagement of Dyslipidaemias of the European Society of Cardiology.
52 Deedwania P, Barter P, Carmena R, Fruchart J‑C, Grundy SM, Haffner S, Kastelein JJP, LaRosa JC, Schachner H, Shepherd J, et al. Reduction of low‑ density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. The Lancet. 2006;368(9539):919–28.
53 Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, et al. The efects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.
54 Kotchen TA, Grim CE, Kotchen JM, et al. Altered Relationship of Blood Pressure to Adiposity in Hypertension. Am J Hypertens 2008;21:284–289.
55 Manrique C, Lastra G, Gardner M, et al. The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress. Med Clin North Am 2009;93:569–582.
56 Kotchen TA, Grim CE, Kotchen JM, et al. Altered Relationship of Blood Pressure to Adiposity in Hypertension. Am J Hypertens 2008;21:284–289.
57 Manrique C, Lastra G, Gardner M, et al. The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress. Med Clin North Am 2009;93:569–582.
58 Simental-Mend´ıa LE, Rodr´ıguez-Moran M, ´Guerrero-Romero F. The product of fasting glucose
and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008;6:299–304.
59 Vasques AC, Novaes FS, de Oliveira MdaS, et al. TyG index performs better than HOMA in a
Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93:e98– e100.
60 Guerrero-Romero F, Villalobos-Molina R, Jimenez-Flores JR, et al. Fasting triglycerides ´ and
glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res 2016; 47:382– 387.
61 da Silva, A., Caldas, A., Hermsdorff, H., Bersch-Ferreira, Â. C., Torreglosa, C. R., Weber, B., &Bressan, J. (2019). Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovascular diabetology, 18(1), 89. https://doi.org/10.1186/s12933-019- 0893-2.
62 Zhao, S. , Yu, S. , Chi, C. , Fan, X. , & Xu, Y. . (2019). Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the northern shanghai study. Cardiovascular Diabetology, 18(1).
63 Shi, W., Xing, L., Jing, L., Tian, Y., Yan, H., Sun, Q., Dai, D., Shi, L., & Liu, S. (2020). Value of triglyceride-glucose index for the estimation of ischemic stroke risk: Insights from a general population. Nutrition, metabolism, and cardiovascular diseases: NMCD, 30(2), 245–253. https://doi.org/10.1016/j.numecd.2019.09.015.
64 Luo, E., Wang, D., Yan, G., Qiao, Y., Liu, B., Hou, J., & Tang, C. (2019). High triglyceride-glucoseindex is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovascular diabetology, 18(1), 150.https://doi.org/10.1186/s12933-019-0957-3.
65 Arauz‐Pacheco C, Lender D, Snell PG, et al. Relationship between insulin sensitivity, hyperinsulinemia, and insulin‐mediated sympathetic activation in normotensive and hypertensive subjects. Am J Hypertens. 1996;9(12 Pt 1):1172‐1178.
66 Takagi M, Tanaka Y, Yamasaki Y, et al. Responsiveness of insulin-induced cardiac sympatheticnerve activation associates with blood pressure regulation in diabetics. Am J Physiol Endocrinol Metab. 2003;284(5):E1022–E1026. doi: 10.1152/ajpendo.00169.2002.
67 Fonseca VA. Insulin resistance, diabetes, hypertension, and reninangiotensin system inhibition:reducing risk for cardiovascular disease. J Clin Hypertens. 2006;8(10):713‐720.
68 Khalil RA. Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension. Curr Mol Pharmacol. 2011;4(3):176‐186.
69 Frank HJ, Levin ER, Hu RM, et al. Insulin stimulates endothelin binding and action on culturedvascular smooth muscle cells. Endocrinology. 1993;133(3):1 092. doi: 10.1210/endo.133.3.8365355.
70 Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, et al. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort. Prev Med. 2016;86:99–105. doi:10.1016/j.ypmed.2016.01.022.
71 Helal, I., Fick-Brosnahan, G., Reed-Gitomer, B. et al. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8, 293–300 (2012). https://doi.org/10.1038/nrneph.2012.19
72 Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 2005;28:2013–2018.
73 Wilson PW, Meigs JB, Sullivan L, Fox CS, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007;167:1068–1074.
74 Ren Y, Ren Q, Lu J et al. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China. Diabetes Metab Res Rev. 2018 Feb;34(2).
75 Budoff M. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway ofCardiovascular Disease. Am J Cardiol. 2016 Jul 1;118(1):138-145.
76 Tenenbaum A, Klempfner R, Fisman EZ. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol. 2014;13:159.
77 Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S. Glucose-induced up-regulation of CD36mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia. 2005;48(7):1401-1410.
78 Zhou SX, Huo DM, He XY et al. High glucose/lysophosphatidylcholine levels stimulateextracellular matrix deposition in diabetic nephropathy via platelet‑activating factor receptor. Mol Med Rep. 2018;17(2):2366-2372.